ORGANON & CO. (OGN)
European Commission (EC) Approves Henlius and Organon’s POHERDY® (pertuzumab), the First Approved Biosimilar to PERJETA (pertuzumab) in Europe
European Commission (EC) Approves Henlius and Organon’s POHERDY® (pertuzumab), the First Approved Biosimilar to PERJETA (pertuzumab) in Europe
📈 **POSITIVE** • High confidence analysis (89%) • Strong positive business development • Significant competitive advantage **Sentiment:** Positive (95%) **Content type:** Business